MedPath

To study the effect of Nalbuphine in prolongation of duration of post-operative analgesia when it is added as an adjuvant to 0.5%Ropivacaine in ultrasound guided supraclavicular brachial plexus blocks

Phase 3
Not yet recruiting
Conditions
Fracture of forearm,
Registration Number
CTRI/2022/06/043470
Lead Sponsor
Department of Anaesthesia
Brief Summary

In this double blinded randomized controlled interventional study, we will compare the analgesic effect of nalbuphine as an adjuvant to 0.5% ropivacaine in ultrasound guided supraclavicular brachial plexus nerve blocks  with the analgesic effect of 0.5% ropivacaine alone in ultrasound guided supraclavicular brachial plexus nerve blocks .

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
64
Inclusion Criteria
  • 1.participant of fracture forearm surgeries under USG guided supraclavicular block.
  • ASA physical status class 1and 2 .
  • patients willing to participate.
Exclusion Criteria
  • Patients with a history of allergy or hypersensitivity to either local anaesthetics or opioid group of drugs.
  • Any contra indication to peripheral nerve block.
  • 3.impaired ability to communicate.
  • 4.patients with raised intracranial tension.
  • 5.pregnancy.
  • 6.patient with coagulation disorder.
  • 7.local infection/swelling at the site of injection.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Duration of post-operative analgesia according to NRS scale.(time of first request of rescue analgesia).Every 30 minutes in first hour then every one hourly in next twelve hours.
Secondary Outcome Measures
NameTimeMethod
Proportion of cases with complicationsPost operative period
Side-effectsIf any
Mean duration of analgesiaIn post-operative period
Haemodynamic parametersIntraoperative period

Trial Locations

Locations (1)

SMS MEDICAL COLLEGE AND HOSPITAL, JAIPUR

🇮🇳

Jaipur, RAJASTHAN, India

SMS MEDICAL COLLEGE AND HOSPITAL, JAIPUR
🇮🇳Jaipur, RAJASTHAN, India
Dr CHITRA SINGH
Principal investigator
9166609479
raghuvanshichitra@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.